Related Experiment Videos
An automatic autotransfusion system with a centrifugal pump: a hematologic evaluation in dogs
H J ten Duis1, M P Harder, E Wabeke
1Department of Traumatology, University Hospital Groningen, The Netherlands.
Surgery
|January 1, 1988
Summary
A centrifugal pump in an on-line autotransfusion system (ATS) offers safety advantages over diaphragm pumps for massive blood loss. Hemocompatibility and ease of operation were comparable, making it the preferred choice.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Critical Care Medicine
Background:
- On-line autotransfusion systems (ATS) are crucial for managing massive blood loss during surgery.
- Key requirements for ATS include reinfusion capacity, hemocompatibility, air embolism prevention, and operational simplicity.
- Previous studies evaluated diaphragm pumps; this research focuses on centrifugal pumps.
Purpose of the Study:
- To evaluate the hemocompatibility and pumping characteristics of a centrifugal pump in an on-line ATS.
- To compare the centrifugal pump's performance against a previously tested diaphragm pump.
- To assess the safety and operational ease of the centrifugal pump within the ATS.
Main Methods:
- A centrifugal pump was integrated as the outflow pump into an existing pneumatically driven ATS.
- The system was tested for hemocompatibility and pumping performance.
- Operational ease and safety were assessed by non-specialized personnel.
Main Results:
- The centrifugal pump demonstrated comparable hemocompatibility to the diaphragm pump.
- The centrifugal pump offers advantages such as preventing massive air embolism and avoiding tubing rupture upon obstruction.
- The ATS with the centrifugal pump was easily and safely operated by non-specialized personnel.
Conclusions:
- The centrifugal pump is a suitable and safe outflow pump for on-line autotransfusion systems.
- Its superior pumping characteristics and safety features make it the preferred choice over diaphragm pumps.
- The system's ease of operation supports its use in clinical settings for managing massive blood loss.